01
Sample collection
A tumour sample and/or a routine blood draw is used. We arrange the logistics in cooperation with your doctor.
FOR PATIENTS AND FAMILIES
Understand your tumour better. Clearly.
Tumour molecular analysis gives your doctor a more detailed view of the biology of the disease. This page explains what each level includes and what it can realistically mean for you — without unnecessary promises.
Information material — always in cooperation with your doctor. No obligation · confidential · GDPR compliant.
1
Insight — entry level, analysing the tumour at DNA and RNA level + a blood test (liquid biopsy).
2
Advanced — a deeper view for more complex or progressing disease.
3
Complete — the most comprehensive profile for rare and clinically challenging cases.
What is tumour molecular analysis?
Every tumour is different. Molecular analysis reads the “instructions” that guide how a tumour behaves — its DNA, RNA and other layers of information. The aim is to give your oncologist more precise information so they can consider whether a more targeted treatment or a suitable clinical trial may exist for you.
02
Analysis and interpretation
We process the sample and the results are assessed by an expert team — a molecular biologist, bioinformatician and oncologist.
03
Report for your doctor
Your oncologist receives a clear report and discusses the next steps with you. Your doctor remains your primary contact.
A CANDID EXPLANATION
What the analysis can — and cannot — promise
- Molecular analysis is a tool that supports better-informed decisions — it is not a guarantee of a cure.
- It may identify molecular changes that can sometimes open an option for targeted treatment or a clinical trial.
- It does not guarantee that such a treatment will be found for you — no actionable target is found for some patients.
- It does not guarantee a better treatment outcome; studies show benefit mainly in more precise treatment selection, not for every patient.
- Every step is decided by your treating doctor based on the complete clinical picture.
- OmixMe services provide scientific and informational support for your doctor — they do not constitute healthcare, diagnosis or treatment. The analyses are for research and informational purposes and are not a validated diagnostic test.
THREE LEVELS
A scope of analysis suited to your situation
Each level expands the depth of the molecular view. The appropriate scope is considered together with your doctor.
Insight
Level 1 of 3Molecular characterisation of the tumour at DNA and RNA level.
The entry level already includes tumour analysis at both DNA and RNA level, together with liquid biopsy and expert assessment of the results.
When we recommend it
- newly diagnosed patient
- before first-line treatment
- a second opinion based on molecular data
- when comprehensive genetic analysis has not yet been performed
Advanced
Level 2 of 3Advanced multi-omic tumour analysis.
Includes everything in Insight and adds single-cell analysis, a microRNA profile and DNA methylation.
When we recommend it
- metastatic disease
- tumour recurrence
- insufficient response to treatment
- searching for additional options
- complex cases
Complete
Level 3 of 3The most comprehensive multi-omic tumour profile.
Includes everything in Advanced and adds whole-genome sequencing (WGS), single-cell WGS and ATAC-seq / ChIP-seq.
When we recommend it
- rare tumours
- aggressive tumours
- repeated treatment failure
- clinically complicated cases
Compare the levels
| Analysis | What it provides | Insight | Advanced | Complete |
|---|---|---|---|---|
| Tumour DNA analysis | Looks for gene changes that may open an option for targeted treatment. | ✓ | ✓ | ✓ |
| RNA profiling | Shows which genes are active in the tumour — complementing the DNA view. | ✓ | ✓ | ✓ |
| Liquid biopsy — blood test (ctDNA) | Monitoring the tumour from a routine blood draw, without another procedure. | ✓ | ✓ | ✓ |
| Single-cell analysis | Distinguishes different cell types in the tumour, including potentially resistant ones. | — | ✓ | ✓ |
| microRNA | An additional regulatory layer that may refine the view of the tumour. | — | ✓ | ✓ |
| DNA methylation | Epigenetic changes; in some tumours they help determine the type more precisely. | — | ✓ | ✓ |
| Whole-genome sequencing (WGS) | The broadest view of tumour DNA, including changes outside common panels. | — | — | ✓ |
| Single-cell WGS | A view of tumour evolution and its resistant cell subgroups. | — | — | ✓ |
| ATAC-seq and ChIP-seq | Advanced analyses of tumour regulation for the most complex cases. | — | — | ✓ |
| Clear report | Results explained for you and your doctor. | ✓ | ✓ | ✓ |
| Doctor consultation | Coordination and communication with your oncologist throughout the process. | ✓ | ✓ | ✓ |
✓ included · — not part of this level
You do not need to decide on everything at once
You can begin with a lower level and add a higher one later if the first results and your doctor's recommendation show that an expanded analysis makes sense for you. Analyses already completed are not repeated.
Your doctor leads the entire process.
We take care of logistics, laboratory work, interpretation and communication with the oncologist. You and your family can focus on what matters most.
01
Connect us with your doctor
We send your oncologist all the necessary information.
02
Your doctor prepares the documentation and sample
The documents and sample are prepared for processing.
03
We perform the analysis
The report is usually available within 14–30 days after the sample is confirmed.
04
Your doctor receives and discusses the report
Together with you, they determine the next steps.
Connect us with your doctor.
No obligation · confidential · GDPR compliant.
OmixMe services provide scientific and informational decision support for the treating doctor — they do not constitute healthcare, diagnosis or treatment, and OmixMe is not a healthcare provider. Molecular analysis does not guarantee that a targeted therapy will be found for a patient or a better treatment outcome; clinically actionable findings are not identified for every patient. Diagnosis and treatment are determined exclusively by the treating doctor.